Variant report
| Variant | nsv53263 |
|---|---|
| Chromosome Location | chr12:123188976-123193497 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:11)
- CpG islands (count:123)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:11 , 50 per page) page:
1
| No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
|---|---|---|---|---|---|---|
| 1 | CBX3 | chr12:123192855-123193151 | K562 | blood: | n/a | n/a |
| 2 | CEBPB | chr12:123192060-123192294 | HepG2 | liver: | n/a | chr12:123192205-123192216 |
| 3 | CEBPB | chr12:123192177-123192277 | Hela-S3 | cervix: | n/a | chr12:123192205-123192216 |
| 4 | CEBPB | chr12:123192061-123192396 | A549 | lung: | n/a | chr12:123192205-123192216 |
| 5 | CEBPB | chr12:123192198-123192210 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 6 | CEBPB | chr12:123192059-123192377 | IMR90 | lung: | n/a | chr12:123192205-123192216 |
| 7 | GATA2 | chr12:123192789-123193089 | K562 | blood: | n/a | n/a |
| 8 | GATA3 | chr12:123193377-123193611 | T-47D | breast: | n/a | n/a |
| 9 | NR2F2 | chr12:123192809-123193203 | K562 | blood: | n/a | n/a |
| 10 | SPI1 | chr12:123193214-123193362 | K562 | blood: | n/a | n/a |
| 11 | TCF3 | chr12:123193223-123193480 | GM12878 | blood: | n/a | n/a |
| No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr12:123189256-123189306 | PrEC | prostate: | n/a |
| 2 | chr12:123189256-123189306 | PrEC | prostate: | n/a |
| 3 | chr12:123189236-123189286 | Jurkat | blood: | n/a |
| 4 | chr12:123189256-123189306 | AG04449 | skin: | fetal |
| 5 | chr12:123189256-123189306 | MCF-7 | breast: | n/a |
| 6 | chr12:123189256-123189306 | HL-60 | blood: | n/a |
| 7 | chr12:123189236-123189286 | HEEpiC | esophagus: | n/a |
| 8 | chr12:123189256-123189306 | AG04450 | lung: | fetal |
| 9 | chr12:123189236-123189286 | HepG2 | liver: | n/a |
| 10 | chr12:123189256-123189306 | NHDF-neo | bronchial: | n/a |
| 11 | chr12:123189256-123189306 | U87 | brain: | n/a |
| 12 | chr12:123189256-123189306 | PFSK-1 | brain: | n/a |
| 13 | chr12:123189256-123189306 | Hepatocyte | liver: | n/a |
| 14 | chr12:123189236-123189286 | HRPEpiC | eye: | n/a |
| 15 | chr12:123189236-123189286 | H1-hESC | embryonic stem cell: | embryo |
| 16 | chr12:123189236-123189286 | ProgFib | skin: | n/a |
| 17 | chr12:123189256-123189306 | GM19239 | blood: | n/a |
| 18 | chr12:123189256-123189306 | T-47D | breast: | n/a |
| 19 | chr12:123189236-123189286 | SAEC | small airway: | n/a |
| 20 | chr12:123189236-123189286 | SK-N-MC | brain: | n/a |
| 21 | chr12:123189256-123189306 | HCPEpiC | choroid plexus: | n/a |
| 22 | chr12:123189256-123189306 | HRCEpiC | kidney: | n/a |
| 23 | chr12:123189256-123189306 | HCF | heart: | n/a |
| 24 | chr12:123189236-123189286 | Hepatocyte | liver: | n/a |
| 25 | chr12:123189236-123189286 | PFSK-1 | brain: | n/a |
| 26 | chr12:123189236-123189286 | ovcar-3 | ovarian: | n/a |
| 27 | chr12:123189236-123189286 | HEK293 | kidney: | embryo |
| 28 | chr12:123189236-123189286 | HNPCEpiC | eye: | n/a |
| 29 | chr12:123189236-123189286 | SKMC | muscle: | n/a |
| 30 | chr12:123189256-123189306 | Caco-2 | colon: | n/a |
| 31 | chr12:123189256-123189306 | IMR90 | lung: | fetal |
| 32 | chr12:123189236-123189286 | HRE | kidney: | n/a |
| 33 | chr12:123189236-123189286 | GM12892 | blood: | n/a |
| 34 | chr12:123189236-123189286 | RPTEC | kidney: | n/a |
| 35 | chr12:123189256-123189306 | MCF10A-Er-Src | breast: | n/a |
| 36 | chr12:123189256-123189306 | PANC-1 | pancreas: | n/a |
| 37 | chr12:123189256-123189306 | NT2-D1 | testis: | n/a |
| 38 | chr12:123189256-123189306 | K562 | blood: | n/a |
| 39 | chr12:123189256-123189306 | RPTEC | kidney: | n/a |
| 40 | chr12:123189236-123189286 | HIPEpiC | eye: | n/a |
| 41 | chr12:123189256-123189306 | BJ | skin: | n/a |
| 42 | chr12:123189256-123189306 | SKMC | muscle: | n/a |
| 43 | chr12:123189256-123189306 | Hela-S3 | cervix: | n/a |
| 44 | chr12:123189236-123189286 | HUVEC | blood vessel: | n/a |
| 45 | chr12:123189236-123189286 | NH-A | brain: | n/a |
| 46 | chr12:123189256-123189306 | A549 | lung: | n/a |
| 47 | chr12:123189236-123189286 | ECC-1 | luminal epithelium: | n/a |
| 48 | chr12:123189236-123189286 | SK-N-SH | brain: | n/a |
| 49 | chr12:123189236-123189286 | GM06990 | blood: | n/a |
| 50 | chr12:123189256-123189306 | SK-N-SH_RA | brain: | n/a |
| No data |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| HCAR2 | TF binding region |
| HCAR2 | CpG island |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs552272486 | chr12:123188984-123188985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs570923310 | chr12:123188999-123189000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs538450989 | chr12:123189034-123189035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs55736428 | chr12:123189068-123189069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs568766575 | chr12:123189080-123189081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs558635763 | chr12:123189107-123189108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs575705198 | chr12:123189161-123189162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs371698705 | chr12:123189199-123189200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs7305589 | chr12:123189208-123189209 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 10 | rs514019 | chr12:123189211-123189212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs182566283 | chr12:123189219-123189220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs572429835 | chr12:123189237-123189238 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 13 | rs539519297 | chr12:123189246-123189247 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 14 | rs201261312 | chr12:123189248-123189249 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 15 | rs369705338 | chr12:123189250-123189251 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 16 | rs187223452 | chr12:123189256-123189257 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 17 | rs576921353 | chr12:123189257-123189258 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 18 | rs562479730 | chr12:123189260-123189261 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 19 | rs112378089 | chr12:123189285-123189286 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 20 | rs562386642 | chr12:123189286-123189287 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 21 | rs574376330 | chr12:123189294-123189295 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
| 22 | rs541752808 | chr12:123189313-123189314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs559866882 | chr12:123189326-123189327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs575066345 | chr12:123189331-123189332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs551946138 | chr12:123189341-123189342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs151273279 | chr12:123189369-123189370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs376533926 | chr12:123189370-123189371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs140511470 | chr12:123189399-123189400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 29 | rs550387505 | chr12:123189453-123189454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs568703613 | chr12:123189463-123189464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs540961312 | chr12:123189492-123189493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs191550293 | chr12:123189498-123189499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs6489222 | chr12:123189499-123189500 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 34 | rs565898852 | chr12:123189530-123189531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs12303524 | chr12:123189559-123189560 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 36 | rs183347123 | chr12:123189575-123189576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs570128842 | chr12:123189576-123189577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs377117091 | chr12:123189577-123189578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs537184258 | chr12:123189581-123189582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs555920040 | chr12:123189584-123189585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs574315726 | chr12:123189586-123189587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs541687670 | chr12:123189591-123189592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs188855439 | chr12:123189600-123189601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs112247633 | chr12:123189610-123189611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs571901198 | chr12:123189617-123189618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs11323486 | chr12:123189627-123189628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs200339213 | chr12:123189641-123189642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs200700641 | chr12:123189642-123189643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs193086349 | chr12:123189668-123189669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs563966498 | chr12:123189677-123189678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Esophageal cancer | 21851588 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Testicular germ cell tumor | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Malaria | 21533027 | CNVD |
| Chronic lymphocytic leukemia | 22228453 | CNVD |
| Basal cell lymphoma | 17053054 | CNVD |
| Chronic lymphocytic leukemia | 21670202 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Breast cancer | 21949216 | CNVD |
| Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Cancer | 21637783 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Gastrointestinal stromal cancer | 20470368 | CNVD |
| Adenoid cystic carcinoma | 17372589 | CNVD |
| Lung cancer | 18438408 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Glioblastoma multiforme | 21390271 | CNVD |
| Cancer | 20164919 | CNVD |
| Cancer | 16751803 | CNVD |
| Biliary cancer | 20360734 | CNVD |
| Breast cancer | 20360734 | CNVD |
| Coronary artery disease | 20360734 | CNVD |
| Crohn''s disease | 20360734 | CNVD |
| Hypertension | 20360734 | CNVD |
| Rheumatoid arthritis | 20360734 | CNVD |
| Type 1 diabetes | 20360734 | CNVD |
| Type 2 diabetes | 20360734 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Gastrointestinal stromal cancer | 20877625 | CNVD |
| T-cell prolymphocytic leukemia | 17713554 | CNVD |
| Schizophrenia | 18923514 | CNVD |
| Schizophrenia | 22241247 | CNVD |
| Cryptorchidism | 21048976 | CNVD |
| Myeloproliferative neoplasm | 20015882 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Medulloblastoma | 16783165 | CNVD |
| Breast cancer | 21806811 | CNVD |
| Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Beckwith-Wiedemann syndrome | 20648245 | CNVD |
| Developmental delay | 21457577 | CNVD |
| dysmorphic | 21457577 | CNVD |
| Ovine squamous-cell carcinoma | 17599052 | CNVD |
| Olfactory neuroblastoma | 18408657 | CNVD |
| Chordoma | 18071362 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr12:123174000-123199800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
| 2 | chr12:123187800-123198600 | Weak transcription | Adipose Nuclei | Adipose |
| 3 | chr12:123188000-123193600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
| 4 | chr12:123188200-123192000 | Weak transcription | HepG2 | liver |
| 5 | chr12:123188600-123190400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
| 6 | chr12:123190400-123195000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
| 7 | chr12:123192000-123192600 | Enhancers | HepG2 | liver |
| 8 | chr12:123192600-123199800 | Weak transcription | HepG2 | liver |






